Home/Filings/4/0001209191-17-053880
4//SEC Filing

Lingnau Lutz 4

Accession 0001209191-17-053880

CIK 0000906709other

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 6:04 PM ET

Size

5.3 KB

Accession

0001209191-17-053880

Insider Transaction Report

Form 4
Period: 2017-09-22
Lingnau Lutz
Director
Transactions
  • Sale

    Common Stock

    2017-09-22$21.97/sh5,000$109,85027,450 total
Footnotes (2)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]This transaction was executed in multiple trades at prices ranging from $21.80 to $22.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1
  • filerCIK 0001354179

Filing Metadata

Form type
4
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 6:04 PM ET
Size
5.3 KB